skip to main content

Breast Cancer

Mammogram screenings beginning at age 40 would reduce cancer deaths for Black Women

The research, published in Annals of Internal Medicine, suggests that a reduction in breast cancer deaths can be achieved for Black women while maintaining the same ratio of benefits to harms that occurs when white women undergo screening every other year starting at age 50.

Women with genetic mutations fare no worse with breast or ovarian cancer, study finds

Women newly diagnosed with breast or ovarian cancer who are also carriers of cancer-associated mutations like BRCA1 or BRCA2 are no more likely to die of their tumors than those who don’t have the mutations, according to a new study.

Blood Enzyme Activity Level May Indicate Which Breast Cancers Are Slow Growing

Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients with high levels.

Pages